Type 1 interferons as a potential treatment against COVID-19

Interplay between SARS-CoV-2 and the type I interferon response

Sa Ribero, Margarida
Jouvenet, Nolwenn
Dreux, Marlène
Nisole, Sébastien

July 2020

International audienceThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsibl...

COVID‐19: lambda interferon against viral load and hyperinflammation

Evangelos Andreakos
Sotirios Tsiodras

June 2020

Coronavirus disease 2019 (COVID‐19), triggered by the betacoronavirus SARS‐CoV‐2, has become one of ...

THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY

T. P. Ospelnikova
E. M. Noseikina
L. A. Gaiderova
F. I. Ershov

October 2016

Interferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an importa...

Type 1 interferons as a potential treatment against COVID-19

Sallard, Erwan
Lescure, François-Xavier
Yazdanpanah, Yazdan
Mentré, France
Peiffer-Smadja, Nathan

April 2020

Elsevier Public Health emergency CollectionInternational audienceType 1 interferons have a broad ant...

Role of interferons in the treatment of severe acute respiratory syndrome.

Cinatl, Jindrich
Michaelis, Martin
Scholz, Martin
Doerr, Hans Wilhelm

June 2004

Severe acute respiratory syndrome (SARS) is caused by the SARS coronavirus (SCV). The disease appear...

Interferon Production and Potentiality as a therapeutic drug for SARS-CoV-2

Yadav, Pramod
Yadav, Adhishree

March 2023

This review examines the use of interferon as a potential drug against SARS-CoV-2 and other animal c...

Type I interferons and SARS-CoV-2: from cells to organisms

Bastard, Paul
Zhang, Qian
Zhang, Shen-Ying
Jouanguy, Emmanuelle
Casanova, Jean-Laurent

February 2022

International audienceType I interferons (IFNs) have broad and potent antiviral activity. We review ...

The dual sides of interferon induction in COVID-19 treatment

Sadra Nadimi Parashkouhi
Pouria Mosaddeghi
Ashkan Bagheri
Seyed Mohammad Iman Moezzi
Seyed Mostafa Fazel Hoseini
Mitra Farahmandnejad
Amin Maleki
Manica Negahdaripour

March 2021

Coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (S...

Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection

Li, Shifang
Gong, Meijiao
Zhao, FuRong
Shao, JunJun
Xie, Yinli
Zhang, Yongguang
Chang, Huiyun

December 2018

The interferons (IFNs) are a primary defense against pathogens because of the strong antiviral activ...

Interferon Therapy as an Emerging Strategy for Treatment of Covid-19: An Overview

Mohan, Arya B.
Treasa Sabu, Sowparnika
Dharan, Shaiju S.

April 2021

Corona virus disease (COVID-19) is an infectious disease and a type of deadly respiratory pandemic c...

Interferon-β-1a inhibition of severe acute respiratory syndrome-coronavirus 2 in vitro when administered after virus infection

Clementi N.
Ferrarese R.
Criscuolo E.
Diotti R. A.
Castelli M.
Scagnolari C.
Burioni R.
Antonelli G.
Clementi M.
Mancini N.

January 2020

The ongoing coronavirus disease 2019 pandemic has forced the clinical and scientific community to tr...

Synergistic interferon-alpha-based combinations for treatment of sars-cov-2 and other viral infections

Ianevski, Aleksandr
Yao, Rouan
Zusinaite, Eva
Lello, Laura Sandra
Wang, Sainan
Jo, Eunji
Yang, Jaewon
Ravlo, Erlend
Wang, Wei
Lysvand, Hilde
Løseth, Kirsti
Oksenych, Valentyn
Tenson, Tanel
Windisch, Marc P.
Poranen, Minna M.
Nieminen, Anni I.
Nordbø, Svein Arne
Fenstad, Mona H.
Grødeland, Gunnveig
Aukrust, Pål
Trøseid, Marius
Kantele, Anu
Lastauskienė, Eglė
Vitkauskienė, Astra
Legrand, Nicolas
Merits, Andres
Bjørås, Magnar
Kainov, Denis

January 2021

Background: There is an urgent need for new antivirals with powerful therapeutic potential and toler...

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections

Aleksandr Ianevski
Rouan Yao
Eva Zusinaite
Laura Sandra Lello
Sainan Wang
Eunji Jo
Jaewon Yang
Erlend Ravlo
Wei Wang
Hilde Lysvand
Kirsti Løseth
Valentyn Oksenych
Tanel Tenson
Marc P. Windisch
Minna M. Poranen
Anni I. Nieminen
Svein Arne Nordbø
Mona Høysæter Fenstad
Gunnveig Grødeland
Pål Aukrust
Marius Trøseid
Anu Kantele
Eglė Lastauskienė
Astra Vitkauskienė
Nicolas Legrand
Andres Merits
Magnar Bjørås
Denis E. Kainov

December 2021

Background: There is an urgent need for new antivirals with powerful therapeutic potential and toler...

The use of interferon in medicine

Waldemar Pluta
Wioleta Dudzińska
Anna Lubkowska

June 2020

Interferons are low-molecular weight glycoproteins. They are characterized by paracrine and autocrin...

Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection

Clementi, Nicola
Ferrarese, Roberto
Criscuolo, Elena
Diotti, Roberta Antonia
Castelli, Matteo
Scagnolari, Carolina
Burioni, Roberto
Antonelli, Guido
Clementi, Massimo
Mancini, Nicasio

January 2020

The ongoing COVID-19 pandemic has forced the clinical and scientific community to try drug repurposi...

Interplay between SARS-CoV-2 and the type I interferon response

Sa Ribero, Margarida
Jouvenet, Nolwenn
Dreux, Marlène
Nisole, Sébastien

July 2020

International audienceThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsibl...

COVID‐19: lambda interferon against viral load and hyperinflammation

Evangelos Andreakos
Sotirios Tsiodras

June 2020

Coronavirus disease 2019 (COVID‐19), triggered by the betacoronavirus SARS‐CoV‐2, has become one of ...

THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY

T. P. Ospelnikova
E. M. Noseikina
L. A. Gaiderova
F. I. Ershov

October 2016

Interferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an importa...

Type 1 interferons as a potential treatment against COVID-19

Sallard, Erwan
Lescure, François-Xavier
Yazdanpanah, Yazdan
Mentré, France
Peiffer-Smadja, Nathan

April 2020

Elsevier Public Health emergency CollectionInternational audienceType 1 interferons have a broad ant...

Role of interferons in the treatment of severe acute respiratory syndrome.

Cinatl, Jindrich
Michaelis, Martin
Scholz, Martin
Doerr, Hans Wilhelm

June 2004

Severe acute respiratory syndrome (SARS) is caused by the SARS coronavirus (SCV). The disease appear...

Interferon Production and Potentiality as a therapeutic drug for SARS-CoV-2

Yadav, Pramod
Yadav, Adhishree

March 2023

This review examines the use of interferon as a potential drug against SARS-CoV-2 and other animal c...

Type I interferons and SARS-CoV-2: from cells to organisms

Bastard, Paul
Zhang, Qian
Zhang, Shen-Ying
Jouanguy, Emmanuelle
Casanova, Jean-Laurent

February 2022

International audienceType I interferons (IFNs) have broad and potent antiviral activity. We review ...

The dual sides of interferon induction in COVID-19 treatment

Sadra Nadimi Parashkouhi
Pouria Mosaddeghi
Ashkan Bagheri
Seyed Mohammad Iman Moezzi
Seyed Mostafa Fazel Hoseini
Mitra Farahmandnejad
Amin Maleki
Manica Negahdaripour

March 2021

Coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (S...

Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection

Li, Shifang
Gong, Meijiao
Zhao, FuRong
Shao, JunJun
Xie, Yinli
Zhang, Yongguang
Chang, Huiyun

December 2018

The interferons (IFNs) are a primary defense against pathogens because of the strong antiviral activ...

Interferon Therapy as an Emerging Strategy for Treatment of Covid-19: An Overview

Mohan, Arya B.
Treasa Sabu, Sowparnika
Dharan, Shaiju S.

April 2021

Corona virus disease (COVID-19) is an infectious disease and a type of deadly respiratory pandemic c...

Interferon-β-1a inhibition of severe acute respiratory syndrome-coronavirus 2 in vitro when administered after virus infection

Clementi N.
Ferrarese R.
Criscuolo E.
Diotti R. A.
Castelli M.
Scagnolari C.
Burioni R.
Antonelli G.
Clementi M.
Mancini N.

January 2020

The ongoing coronavirus disease 2019 pandemic has forced the clinical and scientific community to tr...

Synergistic interferon-alpha-based combinations for treatment of sars-cov-2 and other viral infections

Ianevski, Aleksandr
Yao, Rouan
Zusinaite, Eva
Lello, Laura Sandra
Wang, Sainan
Jo, Eunji
Yang, Jaewon
Ravlo, Erlend
Wang, Wei
Lysvand, Hilde
Løseth, Kirsti
Oksenych, Valentyn
Tenson, Tanel
Windisch, Marc P.
Poranen, Minna M.
Nieminen, Anni I.
Nordbø, Svein Arne
Fenstad, Mona H.
Grødeland, Gunnveig
Aukrust, Pål
Trøseid, Marius
Kantele, Anu
Lastauskienė, Eglė
Vitkauskienė, Astra
Legrand, Nicolas
Merits, Andres
Bjørås, Magnar
Kainov, Denis

January 2021

Background: There is an urgent need for new antivirals with powerful therapeutic potential and toler...

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections

Aleksandr Ianevski
Rouan Yao
Eva Zusinaite
Laura Sandra Lello
Sainan Wang
Eunji Jo
Jaewon Yang
Erlend Ravlo
Wei Wang
Hilde Lysvand
Kirsti Løseth
Valentyn Oksenych
Tanel Tenson
Marc P. Windisch
Minna M. Poranen
Anni I. Nieminen
Svein Arne Nordbø
Mona Høysæter Fenstad
Gunnveig Grødeland
Pål Aukrust
Marius Trøseid
Anu Kantele
Eglė Lastauskienė
Astra Vitkauskienė
Nicolas Legrand
Andres Merits
Magnar Bjørås
Denis E. Kainov

December 2021

Background: There is an urgent need for new antivirals with powerful therapeutic potential and toler...

The use of interferon in medicine

Waldemar Pluta
Wioleta Dudzińska
Anna Lubkowska

June 2020

Interferons are low-molecular weight glycoproteins. They are characterized by paracrine and autocrin...

Interferon-β-1a inhibition of severe acute respiratory syndrome–Coronavirus 2 in vitro when administered after virus infection

Clementi, Nicola
Ferrarese, Roberto
Criscuolo, Elena
Diotti, Roberta Antonia
Castelli, Matteo
Scagnolari, Carolina
Burioni, Roberto
Antonelli, Guido
Clementi, Massimo
Mancini, Nicasio

January 2020

The ongoing COVID-19 pandemic has forced the clinical and scientific community to try drug repurposi...

Interplay between SARS-CoV-2 and the type I interferon response

Sa Ribero, Margarida
Jouvenet, Nolwenn
Dreux, Marlène
Nisole, Sébastien

July 2020

International audienceThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsibl...

COVID‐19: lambda interferon against viral load and hyperinflammation

Evangelos Andreakos
Sotirios Tsiodras

June 2020

Coronavirus disease 2019 (COVID‐19), triggered by the betacoronavirus SARS‐CoV‐2, has become one of ...

THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY

T. P. Ospelnikova
E. M. Noseikina
L. A. Gaiderova
F. I. Ershov

October 2016

Interferons (IFN) belong to key cytokine? of innate and adaptive immune response and play an importa...

Type 1 interferons as a potential treatment against COVID-19

Abstract

Extracted data

Type 1 interferons as a potential treatment against COVID-19

Abstract

Extracted data

Related items

Related items